Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
NCT ID | NCT02481050 |
Title | Study to Evaluate the Efficacy and Safety of Eribulin Mesylate Administered Biweekly (Q2W) for Subjects With Human Epidermal Growth Factor Receptor 2 (HER2)-Negative Metastatic Breast Cancer |
Recruitment | Completed |
Gender | female |
Phase | Phase II |
Variant Requirements | No |
Sponsors | Eisai Inc. |
Indications | |
Therapies | |
Age Groups: | adult |
Covered Countries | USA |
Facility | Status | City | State | Zip | Country | Details |
---|---|---|---|---|---|---|
Facility #1 | Denver | Colorado | 80218 | United States | Details | |
Facility #1 | Columbia | Maryland | 21044 | United States | Details | |
Facility #1 | Omaha | Nebraska | 68130 | United States | Details | |
Facility #1 | Albany | New York | 12206 | United States | Details | |
Facility #1 | Portland | Oregon | 97213 | United States | Details | |
Facility #1 | Dallas | Texas | 75231 | United States | Details | |
Facility #2 | Dallas | Texas | 75246 | United States | Details | |
Facility #1 | Houston | Texas | 77024 | United States | Details | |
Facility #1 | San Antonio | Texas | 78217 | United States | Details | |
Facility #1 | Tyler | Texas | 75702 | United States | Details | |
Facility #1 | Leesburg | Virginia | 20176 | United States | Details | |
Facility #1 | Winchester | Virginia | 22601 | United States | Details |